This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp & Dohme LLC. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of Patrick Schöpf
Introduction
Patrick Schöpf is a notable inventor recognized for his contributions to the field of molecular biology. He has made significant strides in the development of small molecule inhibitors targeting KRAS proteins. His work is pivotal in advancing therapeutic options for various diseases.
Latest Patents
Patrick Schöpf holds 1 patent for his invention titled "Small Molecule Inhibitors of KRAS Proteins." This patent represents a crucial advancement in the fight against cancers driven by KRAS mutations.
Career Highlights
Patrick Schöpf is currently employed at Merck Sharp & Dohme LLC, a leading global healthcare company. His role involves extensive research and development in the pharmaceutical sector, focusing on innovative solutions to complex health challenges.
Collaborations
Throughout his career, Patrick has collaborated with esteemed colleagues, including Takao Uno and Shuhei Kawamura. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Patrick Schöpf's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions are vital in the ongoing quest for effective treatments against challenging diseases.